BRPI0919975A2 - imunoensaio para galectina-3 - Google Patents

imunoensaio para galectina-3

Info

Publication number
BRPI0919975A2
BRPI0919975A2 BRPI0919975A BRPI0919975A BRPI0919975A2 BR PI0919975 A2 BRPI0919975 A2 BR PI0919975A2 BR PI0919975 A BRPI0919975 A BR PI0919975A BR PI0919975 A BRPI0919975 A BR PI0919975A BR PI0919975 A2 BRPI0919975 A2 BR PI0919975A2
Authority
BR
Brazil
Prior art keywords
galectin
immunoassay
Prior art date
Application number
BRPI0919975A
Other languages
English (en)
Inventor
Pieter Muntendam
Original Assignee
Bg Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bg Medicine Inc filed Critical Bg Medicine Inc
Publication of BRPI0919975A2 publication Critical patent/BRPI0919975A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4724—Lectins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
BRPI0919975A 2008-10-29 2009-10-29 imunoensaio para galectina-3 BRPI0919975A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10936608P 2008-10-29 2008-10-29
PCT/US2009/062616 WO2010096126A1 (en) 2008-10-29 2009-10-29 Galectin-3 immunoassay

Publications (1)

Publication Number Publication Date
BRPI0919975A2 true BRPI0919975A2 (pt) 2015-12-15

Family

ID=41445468

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919975A BRPI0919975A2 (pt) 2008-10-29 2009-10-29 imunoensaio para galectina-3

Country Status (10)

Country Link
US (4) US20100143954A1 (pt)
EP (2) EP2359143A1 (pt)
JP (2) JP5903270B2 (pt)
KR (1) KR101678703B1 (pt)
CN (2) CN102257390B (pt)
AU (1) AU2009340423B2 (pt)
BR (1) BRPI0919975A2 (pt)
CA (1) CA2742265C (pt)
MX (1) MX2011004501A (pt)
WO (1) WO2010096126A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries
EP2222846B1 (en) * 2007-08-10 2017-05-03 Protelix, Inc. Universal fibronectin type iii binding-domain libraries
US8680019B2 (en) * 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
SG178531A1 (en) * 2009-08-25 2012-03-29 Bg Medicine Inc Galectin-3 and cardiac resynchronization therapy
JP5904939B2 (ja) * 2010-05-25 2016-04-20 株式会社島津製作所 大腸がんマーカーガレクチン、採血試料中のガレクチン濃度の分析方法及び大腸がんマーカーガレクチン検出キット
EP2671080A1 (en) * 2011-01-31 2013-12-11 BG Medicine, Inc. Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome
CN102226809B (zh) * 2011-02-13 2014-09-17 倪润洲 检测Galectin-3的时间分辨免疫荧光试剂盒
EP2686689B1 (en) * 2011-03-17 2019-08-07 Critical Care Diagnostics, Inc. Methods predicting risk of an adverse clinical outcome
WO2013169890A1 (en) * 2012-05-08 2013-11-14 Bg Medicine, Inc. Systems and methods for assessing disease risk, status, and prognosis
ES2742291T3 (es) * 2012-09-27 2020-02-13 Siemens Healthcare Diagnostics Inc Cistatina C y Galectina-3 como biomarcadores para la hipertensión arterial pulmonar
EP3182130A4 (en) * 2014-08-14 2018-04-18 Hiroshima University Method and kit for determining risk of preterm birth and/or birth of low-birth-weight baby
US20170363620A1 (en) 2016-06-17 2017-12-21 Abbott Laboratories BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
CN107383192B (zh) * 2017-07-19 2018-08-24 深圳市倍诺博生物科技有限公司 半乳糖凝集素-3检测试剂盒
EP3658172A4 (en) * 2017-07-25 2021-05-05 TrueBinding, Inc. CANCER TREATMENT BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
EP3466975A1 (en) 2017-10-05 2019-04-10 Laboratoire Français du Fractionnement et des Biotechnologies A specific binding molecule directed against galectin-3 protein
JP2021527036A (ja) * 2018-06-07 2021-10-11 パレオン ファーマシューティカルズ インコーポレイテッド 炭水化物を検出するためおよび／またはシグレック媒介障害を治療するための多量体タンパク質
CN113711036A (zh) * 2019-01-30 2021-11-26 真和制药有限公司 抗gal3抗体及其用途
JP7421400B2 (ja) * 2020-03-30 2024-01-24 アークレイ株式会社 ヒトガレクチン－３の分析、検出、測定に関する抗体、方法及びキット
CN111537744B (zh) * 2020-05-26 2023-04-07 上海交通大学医学院附属上海儿童医学中心 一种基于乳脂肪球膜特性的乳凝集素或粘蛋白1的elisa定量检测方法
EP4282873A1 (en) * 2021-01-22 2023-11-29 Ajinomoto Co., Inc. Method for screening dimerized cyclic peptides
CN115902204A (zh) * 2022-09-23 2023-04-04 北京大学第三医院（北京大学第三临床医学院） 一种外泌体形式半乳糖凝集素9的检测方法与试剂盒

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4704692A (en) * 1986-09-02 1987-11-03 Ladner Robert C Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
US5091513A (en) * 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
DK0786469T3 (da) 1990-06-11 2006-07-10 Gilead Sciences Inc Nukleinsyreligander
US6319676B1 (en) * 1995-05-02 2001-11-20 Carter Wallace, Inc. Diagnostic detection device and method
CA2293718A1 (en) * 1997-06-10 1998-12-17 Medlyte Diagnostics, Inc. Methods for early detection of heart disease
US20060166276A1 (en) * 1997-09-05 2006-07-27 Lung Health Diagnostics Pty Ltd Method of diagnosis and agents useful for same
US6818418B1 (en) 1998-12-10 2004-11-16 Compound Therapeutics, Inc. Protein scaffolds for antibody mimics and other binding proteins
AU4055000A (en) * 1999-04-13 2000-11-14 Daniel K. Hsu Galectin expression is induced in cirrhotic liver and hepatocellular carcinoma
WO2001068123A2 (en) * 2000-03-13 2001-09-20 La Jolla Institute For Allergy And Immunology Monocyte chemoattractant activity of galectin-3
KR100395254B1 (ko) * 2000-10-30 2003-08-21 (주)자리타 바이오텍 종양 발생 예측 키트
WO2002039122A2 (en) * 2000-11-09 2002-05-16 Vitivity, Inc. Methods for the identification and the treatment of cardiovascular disease
WO2002074911A2 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
AU2002322066A1 (en) * 2001-06-08 2002-12-23 Mandalmed, Inc. N-terminally truncated galectin-3 and antibodies for treating cancer
US20060019235A1 (en) * 2001-07-02 2006-01-26 The Board Of Trustees Of The Leland Stanford Junior University Molecular and functional profiling using a cellular microarray
US7447594B2 (en) * 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20060141493A1 (en) * 2001-11-09 2006-06-29 Duke University Office Of Science And Technology Atherosclerotic phenotype determinative genes and methods for using the same
US20050014198A1 (en) * 2002-07-11 2005-01-20 Leong Ng Assays and kits for detecting and monitoring heart disease
MXPA05005283A (es) * 2002-11-21 2005-07-25 Wyeth Corp Metodos para diagnostico de rcc y otros tumores solidos.
JP2004198313A (ja) * 2002-12-19 2004-07-15 Shusuke Inohara 甲状腺腫瘍の診断用キット
US8383158B2 (en) * 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US6889083B2 (en) * 2003-04-21 2005-05-03 Medtronic, Inc. Atrial tracking recovery to restore cardiac resynchronization therapy in dual chamber tracking modes
WO2005020784A2 (en) * 2003-05-23 2005-03-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
WO2004111654A2 (en) * 2003-06-06 2004-12-23 Ciphergen Biosystems, Inc. Serum biomarkers in ischaemic heart disease
US20050106100A1 (en) * 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
DE10347436B4 (de) * 2003-10-13 2007-08-02 Johann Wolfgang Goethe-Universität Frankfurt am Main In vitro Verfahren zur Diagnose der kardiovaskulären Funktionalität von Blut-abgeleiteter zirkulierender Vorläuferzellen (BDP)
WO2006102497A2 (en) * 2005-03-22 2006-09-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
BRPI0612334A2 (pt) * 2005-04-12 2009-01-27 Univ Libre Bruxelles uso de uma abordagem baseada em galectina-1 direcionada para rnai no tratamento do cÂncer
US7632634B2 (en) * 2005-04-15 2009-12-15 University Of Maryland Biotechnology Institute Method and assay for early diagnosis of prostate cancer
US8524454B2 (en) 2006-04-07 2013-09-03 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
EP2016093A1 (en) * 2006-05-05 2009-01-21 Universiteit Maastricht / Carim Peptides for use in diagnosing the presence of ruptured atherosclerotic lesions in an individual
CA2659082A1 (en) * 2006-06-07 2007-12-21 Tethys Bioscience, Inc. Markers associated with arteriovascular events and methods of use thereof
US7536428B2 (en) 2006-06-23 2009-05-19 Microsoft Corporation Concurrent read and write access to a linked list where write process updates the linked list by swapping updated version of the linked list with internal list
UA22569U (en) * 2006-11-29 2007-04-25 V P Komisarenko Inst Of Endocr Method for diagnosing papillary carcinoma of the thyroid gland
SG178531A1 (en) * 2009-08-25 2012-03-29 Bg Medicine Inc Galectin-3 and cardiac resynchronization therapy
MX2012005385A (es) * 2009-11-13 2012-09-12 Bg Medicine Inc Factores de riesgo y prediccion de infarto al miocardio.
JP2013536408A (ja) * 2010-07-02 2013-09-19 ビージー メディシン， インコーポレイテッド ガレクチン−３測定によりモニタリングされるスタチン療法
EP2671080A1 (en) * 2011-01-31 2013-12-11 BG Medicine, Inc. Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome

Also Published As

Publication number Publication date
WO2010096126A1 (en) 2010-08-26
US20100143954A1 (en) 2010-06-10
CN102257390B (zh) 2015-04-01
US20200033367A1 (en) 2020-01-30
CN102257390A (zh) 2011-11-23
JP5903270B2 (ja) 2016-04-13
EP2359143A1 (en) 2011-08-24
CA2742265A1 (en) 2010-08-26
JP2014199261A (ja) 2014-10-23
US20170370944A1 (en) 2017-12-28
CA2742265C (en) 2014-07-15
AU2009340423B2 (en) 2014-07-24
EP3971570A3 (en) 2022-11-09
MX2011004501A (es) 2011-11-18
JP2012507724A (ja) 2012-03-29
CN104198712A (zh) 2014-12-10
AU2009340423A1 (en) 2010-08-26
EP3971570A2 (en) 2022-03-23
KR101678703B1 (ko) 2016-11-23
US20240103018A1 (en) 2024-03-28
KR20110104930A (ko) 2011-09-23

Similar Documents

Publication Publication Date Title
BRPI0919975A2 (pt) imunoensaio para galectina-3
BRPI0907237A2 (pt) Anticorpo anti-cldn6
DE602009000328D1 (de) Parallelmechanismus
ATE542825T1 (de) Substituierte piperidino-dihydrothienopyrimidine
BRPI0914743A2 (pt) estrutura
BRPI0812818A2 (pt) Turbo-reator para aeronave
BRPI0920069A2 (pt) biomarcadores
BRPI1011791A2 (pt) montagem para perfuração de fundo de poço
BRPI0907637A2 (pt) Biomarcadores p53
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
BRPI0817427A2 (pt) Anticorpo anti-bst2
BRPI0812961A2 (pt) estrutura para acondicionamento
DK2278899T3 (da) Bryggemekanisme
BRPI0905074A2 (pt) Desidratador
FI20085899A0 (fi) Puu-Metalli-komposiittirakenne
BRPI0807650A2 (pt) Fecho rosqueado para conexão rosqueada
ES1065835Y (es) Caperuza para cetreria
ES1070148Y (es) Macolla para barrotes mejorada
ES1066304Y (es) Bisagra para canapes
ES1067523Y (es) Tarima para alcorques
ES1063735Y (es) Testero para persiana
ES1065263Y (es) Captafaros para bionda
ES1066110Y (es) Tabique para la construccion
ES1066482Y (es) Pieza constructiva para paramento
ES1066306Y (es) Pieza para corseteria

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL